Mc Guire Investment Group, LLC Crispr Therapeutics Ag Transaction History

Mc Guire Investment Group, LLC

$704 Million
Q3 2024

A detailed history of Mc Guire Investment Group, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Mc Guire Investment Group, LLC holds 57,822 shares of CRSP stock, worth $2.37 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

57,822

Previous 57,870 0.08%

Holding current value

$2.37 Million

Previous $3.13 Million 13.06%

% of portfolio

0.39%

Previous 0.45%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$44.62 - $62.75 $2,141 - $3,012	-48 Reduced 0.08%	57,822 $2.72 Million
Q2 2024 Jul 23, 2024	SELL	$51.17 - $68.18 $6,038 - $8,045	-118 Reduced 0.2%	57,870 $3.13 Million
Q1 2024 Apr 26, 2024	SELL	$60.67 - $89.12 $36,948 - $54,274	-609 Reduced 1.04%	57,988 $3.95 Million
Q4 2023 Jan 12, 2024	SELL	$38.62 - $72.18 $31,243 - $58,393	-809 Reduced 1.36%	58,597 $3.67 Million
Q3 2023 Oct 12, 2023	BUY	$45.39 - $59.0 $107,483 - $139,712	2,368 Added 4.15%	59,406 $2.7 Million
Q2 2023 Jul 18, 2023	BUY	$43.47 - $67.77 $180,009 - $280,635	4,141 Added 7.83%	57,038 $3.2 Million
Q1 2023 Apr 20, 2023	BUY	$41.0 - $56.12 $698,968 - $956,733	17,048 Added 47.56%	52,897 $2.39 Million
Q4 2022 Jan 10, 2023	BUY	$39.19 - $65.67 $1.22 Million - $2.05 Million	31,210 Added 672.77%	35,849 $0
Q3 2022 Oct 13, 2022	BUY	$61.1 - $83.78 $9,165 - $12,567	150 Added 3.34%	4,639 $303,000
Q2 2022 Jul 15, 2022	BUY	$43.23 - $73.83 $34,151 - $58,325	790 Added 21.36%	4,489 $273,000
Q1 2022 Apr 14, 2022	BUY	$53.19 - $79.24 $196,749 - $293,108	3,699 New	3,699 $232,000
Q4 2021 Jan 13, 2022	SELL	$70.09 - $111.29 $143,614 - $228,033	-2,049 Closed	0 $0
Q2 2021 Jul 16, 2021	SELL	$100.84 - $161.89 $14,722 - $23,635	-146 Reduced 6.65%	2,049 $332,000
Q1 2021 Apr 20, 2021	BUY	$110.72 - $210.04 $51,374 - $97,458	464 Added 26.81%	2,195 $267,000
Q4 2020 Jan 13, 2021	SELL	$79.67 - $173.23 $83,653 - $181,891	-1,050 Reduced 37.76%	1,731 $265,000
Q3 2020 Oct 19, 2020	SELL	$78.5 - $100.64 $36,895 - $47,300	-470 Reduced 14.46%	2,781 $233,000
Q2 2020 Jul 14, 2020	BUY	$38.5 - $76.05 $125,163 - $247,238	3,251 New	3,251 $239,000

Others Institutions Holding CRSP

# of Institutions

490

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.2B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Guire Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Guire Investment Group, LLC with notifications on news.

Account

Mc Guire Investment Group, LLC Crispr Therapeutics Ag Transaction History